PRND 3′UTR polymorphism may be associated with behavioral disturbances in Alzheimer disease

Prion

Volumn 6, Issue 1, 2012, Pages 73-80

  Flirski, Marcin ^a   Sieruta, Monika ^a   Golańska, Ewa ^a   Kłoszewska, Iwona ^a   Liberski, Paweł P ^a   Sobów, Tomasz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Alzheimer disease; APOE; Behavioral symptoms; CYP46; Mild cognitive impairment; Polymorphisms; PRND; PRNP

Indexed keywords

3' UNTRANSLATED REGION; AGED; AGGRESSION; ALZHEIMER DISEASE; ANXIETY; APATHY; ARTICLE; BEHAVIOR DISORDER; CLINICAL EVALUATION; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DELUSION; DEMENTIA; EMOTION; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; NEUROPSYCHIATRY; PHENOTYPE; POLAND; PREVALENCE; PROSPECTIVE STUDY; STANDARD; BEHAVIOR; DEMOGRAPHY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; MILD COGNITIVE IMPAIRMENT; PRION; SINGLE NUCLEOTIDE POLYMORPHISM;

GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; PRND PROTEIN, HUMAN;

3' UNTRANSLATED REGIONS; AGED; ALZHEIMER DISEASE; BEHAVIORAL SYMPTOMS; DEMOGRAPHY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GPI-LINKED PROTEINS; HUMANS; MALE; MILD COGNITIVE IMPAIRMENT; POLYMORPHISM, SINGLE NUCLEOTIDE; PRIONS;

EID: 84857198758     PISSN: 19336896     EISSN: 1933690X     Source Type: Journal    
DOI: 10.4161/pri.6.1.18428     Document Type: Article

References (36)

1. Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, et al. Prevalence of dementia in the United States: the aging, demographics and memory study. Neuroepidemiology 2007; 29:125-32; PMID:17975326; http://dx.doi.org/10.1159/000109998.
2. Fernández M, Gobartt AL, Balañá M. COOPERA Study Group. Behavioural symptoms in patients with Alzheimer's disease and their association with cognitive impairment. BMC Neurol 2010; 10:87; PMID:20920205; http://dx.doi.org/10.1186/1471-2377-10-87.
3. Feldman H, Scheltens P, Scarpini E, Hermann N, Mesenbrink P, Mancione L, et al. Behavioral symptoms in mild cognitive impairment. Neurology 2004; 62:1199-201; PMID:15079026.
4. Ballard C, Day S, Sharp S, Wing G, Sorensen S. Neuropsychiatric symptoms in dementia: importance and treatment considerations. Int Rev Psychiatry 2008; 20:396-404; PMID:18925489; http://dx.doi.org/10.1080/09540260802099968.
5. Borroni B, Costanzi C, Padovani A. Genetic susceptibility to behavioural and psychological symptoms in Alzheimer disease. Curr Alzheimer Res 2010; 7:158-64; PMID:19715553; http://dx.doi.org/10.2174/156720510790691173.
6. Flirski M, Sobow T, Kloszewska I. Behavioural genetics of Alzheimer's disease: a comprehensive review. Arch Med Sci 2011; 2:195-210; http://dx.doi.org/10.5114/aoms.2011.22068.
7. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261:921-3; PMID:8346443; http://dx.doi.org/10.1126/science.8346443.
8. Kim J, Basak JM, Holtzman DM. The role of apolipoprotein E in Alzheimer's disease. Neuron 2009; 63:287-303; PMID:19679070; http://dx.doi.org/10.1016/j. neuron.2009.06.026.
9. Papassotiropoulos A, Lütjohann D, Bagli M, Locatelli S, Jessen F, Buschfort R, et al. 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia. J Psychiatr Res 2002; 36:27-32; PMID:11755458; http://dx.doi.org/10.1016/S0022-3956(01)00050-4.
10. Garcia AN, Muniz MT, Souza e Silva HR, da Silva HA, Athayde-Junior L. Cyp46 polymorphisms in Alzheimer's disease: a review. J Mol Neurosci 2009; 39:342-5; PMID:19705089; http://dx.doi.org/10.1007/s12031-009-9227-2.
11. Golanska E, Hulas-Bigoszewska K, Wojcik I, Rieske P, Styczynska M, Peplonska B, et al. CYP46: a risk factor for Alzheimer's disease or a coincidence? Neurosci Lett 2005; 383:105-8; PMID:15936520; http://dx.doi.org/10. 1016/j.neulet.2005.03.049.
12. Palmer MS, Dryden AJ, Hughes JT, Collinge J. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 1991; 352:340-2; PMID:1677164; http://dx.doi.org/10.1038/352340a0.
13. Papassotiropoulos A, Wollmer MA, Aguzzi A, Hock C, Nitsch RM, de Quervain DJ. The prion gene is associated with human long-term memory. Hum Mol Genet 2005; 14:2241-6; PMID:15987701; http://dx.doi.org/10.1093/hmg/ddi228.
14. Martorell L, Valero J, Mulet B, Gutiérrez-Zotes A, Cortés MJ, Jariod M, et al. M129V variation in the prion protein gene and psychotic disorders: relationship to neuropsychological and psychopathological measures. J Psychiatr Res 2007; 41:885-92; PMID:16949098; http://dx.doi.org/10.1016/j. jpsychires.2006.07.003.
15. Del Bo R, Scarlato M, Ghezzi S, Martinelli-Boneschi F, Fenoglio C, Galimberti G, et al. Is M129V of PRNP gene associated with Alzheimer's disease? A case-control study and a meta-analysis. Neurobiol Aging 2006; 27:7701-5.
16. Peoc'h K, Guérin C, Brandel JP, Launay JM, Laplanche JL. First report of polymorphisms in the prion-like protein gene (PRND): implications for human prion diseases. Neurosci Lett 2000; 286:144-8; PMID:10825657; http://dx.doi.org/10.1016/S0304-3940(00)01100-9.
17. Mead S, Beck J, Dickinson A, Fisher EM, Collinge J. Examination of the human prion protein-like gene doppel for genetic susceptibility to sporadic and variant Creutzfeldt-Jakob disease. Neurosci Lett 2000; 290:117-20; PMID:10936691; http://dx.doi.org/10.1016/S0304-3940(00)01319-7.
18. Golanska E, Hulas-Bigoszewska K, Rutkiewicz E, Styczynska M, Peplonska B, Barcikowska M, et al. Polymorphisms within the prion (PrP) and prion-like protein (Doppel) genes in AD. Neurology 2004; 62:313-5; PMID:14745079.
19. Borroni B, Grassi M, Agosti C, Costanzi C, Archetti S, Franzoni S, et al. Genetic correlates of behavioral endophenotypes in Alzheimer disease: role of COMT, 5-HTTLPR and APOE polymorphisms. Neurobiol Aging 2006; 27:1595-603; PMID:16257094; http://dx.doi.org/10.1016/j.neurobiolaging.2005.09.029.
20. Pritchard AL, Harris J, Pritchard CW, Coates J, Haque S, Holder R, et al. The effect of the apolipoprotein E gene polymorphisms and haplotypes on behavioural and psychological symptoms in probable Alzheimer's disease. J Neurol Neurosurg Psychiatry 2007; 78:123-6; PMID:16980336; http://dx.doi.org/10.1136/ jnnp.2006.092122.
21. Zdanys KF, Kleiman TG, MacAvoy MG, Black BT, Rightmer TE, Grey M, et al. Apolipoprotein E epsilon4 allele increases risk for psychotic symptoms in Alzheimer's disease. Neuropsychopharmacology 2007; 32:171-9; PMID:16841077; http://dx.doi.org/10.1038/sj.npp.1301148.
22. Holmes C, Russ C, Kirov G, Aitchison KJ, Powell JF, Collier DA, et al. Apolipoprotein E: depressive illness, depressive symptoms and Alzheimer's disease. Biol Psychiatry 1998; 43:159-64; PMID:9494696; http://dx.doi.org/10. 1016/S0006-3223(97)00326-0.
23. Craig D, Hart DJ, Passmore AP. Genetically increased risk of sleep disruption in Alzheimer's disease. Sleep 2006; 29:1003-7; PMID:16944667.
24. Yesavage JA, Friedman L, Kraemer H, Tinklenberg JR, Salehi A, Noda A, et al. Sleep/wake disruption in Alzheimer's disease: APOE status and longitudinal course. J Geriatr Psychiatry Neurol 2004; 17:20-4; PMID:15018693; http://dx.doi.org/10.1177/0891988703261994.
25. Stopa EG, Volicer L, Kuo-Leblanc V, Harper D, Lathi D, Tate B, et al. Pathologic evaluation of the human suprachiasmatic nucleus in severe dementia. J Neuropathol Exp Neurol 1999; 58:29-39; PMID:10068311; http://dx.doi.org/10. 1097/00005072-199901000-00004.
26. Schröder B, Franz B, Hempfling P, Selbert M, Jürgens T, Kretzschmar HA, et al. Polymorphisms within the prion-like protein gene (Prnd) and their implications in human prion diseases, Alzheimer's disease and other neurological disorders. Hum Genet 2001; 109:319-25; PMID:11702213; http://dx.doi.org/10.1007/s004390100591.
27. Infante J, Llorca J, Rodero L, Palacio E, Berciano J, Combarros O. Polymorphism at codon 174 of the prion-like protein gene is not associated with sporadic Alzheimer's disease. Neurosci Lett 2002; 332:213-5; PMID:12399017; http://dx.doi.org/10.1016/S0304-3940(02)00941-2.
28. Ferrer I, Freixas M, Blanco R, Carmona M, Puig B. Selective PrP-like protein, doppel immunoreactivity in dystrophic neurites of senile plaques in Alzheimer's disease. Neuropathol Appl Neurobiol 2004; 30:329-37; PMID:15305978; http://dx.doi.org/10.1111/j.1365-2990.2003.00534.x.
29. Moore RC, Lee IY, Silverman GL, Harrison PM, Strome R, Heinrich C, et al. Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel. J Mol Biol 1999; 292:797-817; PMID:10525406; http://dx.doi.org/10.1006/jmbi.1999.3108.
30. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-44; PMID:6610841.
31. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56:303-8; PMID:10190820; http://dx.doi.org/10.1001/archneur.56.3.303.
32. Morris JC. Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr 1997; 9:173-6; PMID:9447441; http://dx.doi.org/10.1017/S1041610297004870.
33. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-98; PMID:1202204; http://dx.doi.org/10.1016/0022- 3956(75)90026-6.
34. Cummings JL. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology 1997; 48:10-6; PMID:9153155.
35. Chapman J, Estupiñan J, Asherov A, Goldfarb LG. A simple and efficient method for apolipoprotein E genotype determination. Neurology 1996; 46:1484-5; PMID:8628509.
36. Papassotiropoulos A, Streffer JR, Tsolaki M, Schmid S, Thal D, Nicosia F, et al. Increased brain beta-amyloid load, phosphorylated tau and risk of Alzheimer disease associated with an intronic CYP46 polymorphism. Arch Neurol 2003; 60:29-35; PMID:12533085; http://dx.doi.org/10.1001/archneur.60.1.29.